Literature DB >> 8175150

Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation.

R Gomis1, J Fernández-Alvarez, P Pizcueta, M Fernández, R Casamitjana, J Bosch, J Rodés.   

Abstract

Increased circulating insulin and glucagon levels are a common observation in patients with cirrhosis, as well as in portal hypertensive models. Hyperinsulinemia and hyperglucagonemia may be caused either by increased beta- and alpha-cell secretion or by defective hepatic clearance of these hormones. To elucidate whether an abnormal endocrine pancreatic function might contribute to the hyperinsulinism or to the hyperglucagonism observed in chronic portal hypertension, insulin and glucagon secretion were measured in vitro in isolated pancreatic islets from rats with partial portal vein ligated and rats with cirrhosis caused by carbon tetrachloride poisoning. Both rats with partial portal vein ligation and rats with cirrhosis caused by carbon tetrachloride poisoning exhibited hyperinsulinism and hyperglucagonism as compared with control rats. Isolated pancreatic islets from both experimental portal hypertensive models showed an impaired insulin secretion after glucose stimulation. On the contrary, glucagon secretion was significantly increased, and there was a markedly enhanced response to arginine. This increased in vitro glucagon production could not be corrected, even in the presence of high glucose concentrations in the incubation medium. Therefore our data show that although hyperglucagonism in rats with partial portal vein ligation and in rats with cirrhosis caused by carbon tetrachloride poisoning is promoted by an enhanced alpha-cell secretion, hyperinsulinism is associated with impaired beta-cell secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175150

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Plasma betatrophin levels in patients with liver cirrhosis.

Authors:  Maria Teresa Arias-Loste; Maria Teresa García-Unzueta; Susana Llerena; Paula Iruzubieta; Angela Puente; Joaquín Cabezas; Carmen Alonso; Antonio Cuadrado; José Antonio Amado; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

2.  Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion.

Authors:  Taira Kuroda; Masashi Hirooka; Mitsuhito Koizumi; Hironori Ochi; Yoshiko Hisano; Kenji Bando; Bunzo Matsuura; Teru Kumagi; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-10-05       Impact factor: 7.527

3.  Pathophysiology of portal hypertension and esophageal varices.

Authors:  Hitoshi Maruyama; Osamu Yokosuka
Journal:  Int J Hepatol       Date:  2012-05-15

Review 4.  Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 5.  Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Authors:  Ramesh Kumar; Diego García-Compeán; Tanmoy Maji
Journal:  World J Hepatol       Date:  2022-07-27

6.  Insulin Resistance and Portal Vein Thrombosis.

Authors:  Nay Linn Aung; Fiona J Cook
Journal:  Clin Diabetes       Date:  2019-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.